Exact Mass: 676.3095

Nulev

C34H48N2O10S (676.303)

Hyoscyamine Sulfate is the sulfate salt of a belladonna alkaloid derivative and the levorotatory form of racemic atropine isolated from the plants Hyoscyamus niger or Atropa belladonna, which exhibits anticholinergic activity. Hyoscyamine functions as a non-selective, competitive antagonist of muscarinic receptors, thereby inhibiting the parasympathetic activities of acetylcholine on the salivary, bronchial, and sweat glands, as well as the eye, heart, bladder, and gastrointestinal tract. These inhibitory effects cause a decrease in saliva, bronchial mucus, gastric juices, and sweat. Furthermore, its inhibitory action on smooth muscle prevents bladder contraction and decreases gastrointestinal motility. The 3(S)-endo isomer of atropine.

AKOS015961064

C34H48N2O10S (676.303)

Aphelasteroside B

C32H52O13S (676.3128)

3,8,14,17,20-Pentaacetyl-7-(2-methylbutanoyl)-synadenol

C35H48O13 (676.3095)

briaexcavatin F

C35H48O13 (676.3095)

19-Hydroxy-3-methoxyaglaine C

C37H44N2O10 (676.2996)

C35H48O13

C35H48O13 (676.3095)

1alpha,2alpha-diacetoxy-8beta-isobutanoyloxy-9alpha-benzoyloxy-13-(alpha-methyl)butanoyloxy-4beta,6beta-dihydroxy-beta-dihydroagarofuran|1beta,2beta-diacetoxy-4alpha,6alpha-dihydroxy-8alpha-isobutanoyloxy-9beta-benzoyloxy-15-(alpha-methyl)butanoyloxy-beta-dihydroagrofuran

C35H48O13 (676.3095)

Limbonin

C35H48O13 (676.3095)

aleppicatine A

C35H48O13 (676.3095)

Angulatin E

C35H48O13 (676.3095)

Atropine sulfate

C34H48N2O10S (676.303)

(6-Methyl-6-azabicyclo[3.1.1]heptan-3-yl)methyl 3-hydroxy-2-phenylpropanoate;sulfuric acid

C34H48N2O10S (676.303)

SMGDG O-23:5;O

C32H52O13S (676.3128)

SQDG 23:4;O

C32H52O13S (676.3128)

ST 29:6;O7;GlcA

C35H48O13 (676.3095)

ST 29:7;O8;Hex

C35H48O13 (676.3095)

4,7,8,15,16-pentakis(acetyloxy)-5,9,12,12-tetramethyl-17-oxapentacyclo[7.6.2.0¹,¹⁰.0³,⁷.0¹¹,¹³]heptadecan-2-yl 2-methylbut-2-enoate

C35H48O13 (676.3095)

19-hydroxy-3'-methoxyaglaine c

C37H44N2O10 (676.2996)

{"Ingredient_id": "HBIN002194","Ingredient_name": "19-hydroxy-3'-methoxyaglaine c","Alias": "NA","Ingredient_formula": "C37H44N2O10","Ingredient_Smile": "CCC(C)(C(=O)NC1CCCN1C(=O)C2C(C3(C(C2(C4=C(C=C(C=C4O3)OC)OC)O)O)C5=CC(=C(C=C5)OC)OC)C6=CC=CC=C6)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10378","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

1α,2α-diacetoxy-8β-isobutanoyloxy-9α-benzoyl-oxy-13-(α-methyl)butanoyloxy-4β,6β-dihydroxy-β-dihydroagarofuran

C35H48O13 (676.3095)

{"Ingredient_id": "HBIN002274","Ingredient_name": "1\u03b1,2\u03b1-diacetoxy-8\u03b2-isobutanoyloxy-9\u03b1-benzoyl-oxy-13-(\u03b1-methyl)butanoyloxy-4\u03b2,6\u03b2-dihydroxy-\u03b2-dihydroagarofuran","Alias": "NA","Ingredient_formula": "C35H48O13","Ingredient_Smile": "CCC(C)C(=O)OCC12C(C(CC(C13C(C(C(C2OC(=O)C4=CC=CC=C4)OC(=O)C(C)C)C(O3)(C)C)O)(C)O)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5311","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

n-{1-[9-(3,4-dimethoxyphenyl)-1,12-dihydroxy-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl}-2-hydroxy-2-methylbutanimidic acid

C37H44N2O10 (676.2996)

(2r)-n-[(2s)-1-[(1r,9r,10s,11r,12r)-9-(3,4-dimethoxyphenyl)-1,12-dihydroxy-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid

C37H44N2O10 (676.2996)

4,5-bis(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-6-{[(3-methylbutanoyl)oxy]methyl}-8-[(2-methylpropanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C35H48O13 (676.3095)

(1s,2s,3e,5r,7s,8s,9r,10e,12s,13s,14s)-2,8,13-tris(acetyloxy)-3,10-bis[(acetyloxy)methyl]-6,6,14-trimethyl-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadeca-3,10-dien-9-yl (2r)-2-methylbutanoate

C35H48O13 (676.3095)

(1r,2s,4s,5r,6s,7s,8s,9r,12r)-4,5-bis(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-6-{[(3-methylbutanoyl)oxy]methyl}-8-[(2-methylpropanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C35H48O13 (676.3095)

(1r,2r,3r,4s,5s,7r,8r,9r,10r,11s,13s,15s,16r)-4,7,8,15,16-pentakis(acetyloxy)-5,9,12,12-tetramethyl-17-oxapentacyclo[7.6.2.0¹,¹⁰.0³,⁷.0¹¹,¹³]heptadecan-2-yl (2e)-2-methylbut-2-enoate

C35H48O13 (676.3095)

(1s,2s,4s,5r,6s,7s,8s,9s,12r)-4,5-bis(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-8-[(2-methylpropanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C35H48O13 (676.3095)

4,5-bis(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-8-[(2-methylpropanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C35H48O13 (676.3095)

(1s,2s,3s,4r,5s,7s,8r,9r,10s,12z,14s,17r)-2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl pent-4-enoate

C35H48O13 (676.3095)

2,8,13-tris(acetyloxy)-3,10-bis[(acetyloxy)methyl]-6,6,14-trimethyl-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadeca-3,10-dien-9-yl 2-methylbutanoate

C35H48O13 (676.3095)

(2s)-n-[(2s)-1-[(1r,9r,10s,11r,12s)-9-(3,4-dimethoxyphenyl)-1,12-dihydroxy-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid

C37H44N2O10 (676.2996)

2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl pent-4-enoate

C35H48O13 (676.3095)